Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The Univer
Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.
Paxlovid Use Could Reduce Hospitalizations, Deaths, Costs miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Written by Erika Watts on May 4, 2021 Fact checked by Ferdinand Lali, Ph.D.
A recent study tests combinations of drugs for the treatment of COVID-19. Himanshu Vyas/Hindustan Times via Getty Images
Although vaccines are now available for most of the world, a more successful treatment for COVID-19 is still necessary.
Researchers believe that a combination of Food and Drug Administration (FDA)-approved antiviral medications could help people with SARS-CoV-2 infections.
They combined the drug remdesivir, which is effective against Ebola, with drugs that can treat hepatitis C.
With worldwide COVID-19 cases on the rise again, the race to find an effective treatment for the disease continues.